GMP Human IL-6 Protein

DMF
Premium grade (Pre-GMP) version IL6-H4218 is now available for seamless transition.
1/11
+8 View all
製品番号/仕様
価格
Availability
数量
GMP-L06H27-50ug
$470.00
In Stock - Delivery in 1-2 business days
GMP-L06H27-1mg (50ug X 20)
$4,080.00
In Stock - Delivery in 2-3 weeks
GMP-L06H27-10mg (50ug X 200)
$28,560.00
GMP-L06H27
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Product Details

IL-6 (Interleukin-6)​ is a multifunctional cytokine involved in immune regulation and hematopoiesis, acting synergistically with IL-3 and SCF to stimulate early hematopoietic progenitor proliferation. In HSC culture, IL-6 promotes progenitor cell expansion and can support the maintenance of stem and progenitor cell activity. During iPSC differentiation toward HSCs, IL-6 aids in the transition from mesoderm to hematopoietic commitment and enhances the functional output of hematopoietic progenitors, especially in synergy with IL-3 and thrombopoietin.

Product Features and Advantages
  • Specific HSC Expansion Driver​: Efficiently supports hematopoietic stem cell expansion and hPSC-derived hematopoietic stem and progenitor cell differentiation, validated in multiple clinical trials and cell manufacturing processes.
  • Reliable Large-Scale Supply: Ensures batch production capacity, supporting robust and consistent manufacturing scale-up.
  • High Lot-to-Lot Consistency​: Ensures reliable and reproducible performance in every batch, supporting scalable applications.
GMP Platform Advantages
  • Quality Assurance: Global QMS with comprehensive and stringent QC release criteria.
  • End-to-End GMP Compliance: Full manufacturing and QC under a cGMP system.
  • Comprehensive Control of Adventitious Agents: Stringent biosafety from cell banks to final release.
  • Comprehensive Regulatory Support: Includes RSF and DMF to meet global requirements.
  • Resilient Supply Chain: Intelligent modular facilities ensure a stable global supply.
  • Professional Support: Extensive manufacturing and application expertise to accelerate development.
Source

GMP Human IL-6 Protein (GMP-L06H27) is expressed from human 293 cells (HEK293). It contains AA Val 30 - Met 212 (Accession # P05231).

Molecular Characterization

This protein carries no "tag".

The protein has a calculated MW of 20.8 kDa. The protein migrates as 23-29 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

N-terminal Sequence Analysis

Val-Pro-Pro-Gly-Glu-Asp-Ser-Lys-Asp-Val-Ala-Ala-Pro-His-Arg
(Routinely tested)

Endotoxin

Less than 10 EU/mg, tested by the LAL method in compliance with USP <85> and Ph. Eur. 2.6.14.

Host Cell Protein

<0.5 ng/µg of protein tested by ELISA.

Host Cell DNA

<0.02 ng/μg of protein tested by qPCR.

Sterility

Sterility testing was performed using the membrane filtration method in compliance with USP <71> and Ph. Eur. 2.6.1.

Mycoplasma

Negative

Purity

>95% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.

Contact us for customized product form or formulation.

Vial Specification

2R (13 mm neck finish)

Shipping and Storage

This product is supplied and shipped on blue ice.

Upon receipt, store it immediately at -20°C or lower for long term storage.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 5 years in lyophilized state;
  • -70°C for 12 months under sterile conditions after reconstitution.

バックグランド

Interleukin 6 (IL-6) is also known as HGF, BSF2,HSF, IFNB2 and IL-6, originally identified as a B cell differentiation factor, is a multifunctional cytokine that regulates immune responses, hematopoiesis, acute phase responses, and inflammatory reactions.It is secreted by T cells, macrophages , monocytes, fibroblasts,endothelial cells,et.al. to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein. IL-6 is relevant to many disease processes such as diabetes,atherosclerosis, depression,Alzheimer's Disease,systemic,lupus erythematosus,prostate cancer and rheumatoid arthritis. Advanced/metastatic cancer patients have higher levels of IL-6 in their blood.Hence there is an interest in developing anti-IL-6 agents as therapy against many of these diseases.